Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Comparative Cohort Non-interventional Epidemiological Study of the Efficacy and Safety of Enzyme Replacement Therapy in Russian Patients With Fabry Disease

NCT06880250 is registered in ClinicalTrials.gov with NPO Petrovax as lead sponsor.

NCT NCT06880250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06880250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Comparative Cohort Non-interventional Epidemiological Study of the Efficacy and Safety of Enzyme Replacement Therapy in Russian Patients With Fabry Disease
Lead sponsor
NPO Petrovax
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 24, 2025
Completion date
January 31, 2027
Enrollment
100 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

fabry disease